Reaction
Gastrointestinal Stoma Output Increased reporting signals
As of the last recalculation, Gastrointestinal Stoma Output Increased appears in 457 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is TEDUGLUTIDE (PRR 1,335.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Teduglutide | 212 | 1,335.8 | 1,357.2 |
| Diphenoxylate Hydrochloride And Atropine Sulfate | 26 | 91.6 | 91.8 |
| Loperamide Hydrochloride Oral | 16 | 73.9 | 74.0 |
| Loperamide Hcl | 16 | 58.7 | 58.7 |
| Vedolizumab | 87 | 56.6 | 56.6 |
| Loperamide Hydrochloride | 45 | 50.7 | 50.8 |
| Cholestyramine | 11 | 42.4 | 42.5 |
| Loperamide Hydrochloride And Dimethicone | 25 | 37.5 | 37.5 |
| Risankizumab-Rzaa | 30 | 17.8 | 17.8 |
| Bosutinib | 3 | 15.3 | 15.3 |